Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Non-small cell lung cancer (NSCLC)

  • You have access
    Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients
    YUKIKO SHIMODA, TATSUYA YOSHIDA, MASAYUKI SHIRASAWA, TAKAAKI MIZUNO, HITOMI JO, YUJI MATSUMOTO, YUKI SHINNO, YUSUKE OKUMA, YASUSHI GOTO, HIDEHITO HORINOUCHI, NOBORU YAMAMOTO, YASUSHI YATABE, YUICHIRO OHE and NORIKO MOTOI
    Anticancer Research November 2021, 41 (11) 5739-5747; DOI: https://doi.org/10.21873/anticanres.15390
  • You have access
    Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
    KATSUHIKO SHIMIZU, RIKI OKITA, SHINSUKE SAISHO, AI MAEDA, YUJI NOJIMA and MASAO NAKATA
    Anticancer Research August 2018, 38 (8) 4637-4644; DOI: https://doi.org/10.21873/anticanres.12768
  • You have access
    In Vitro and In Vivo Antitumor Effects of Pyrimethamine on Non-small Cell Lung Cancers
    MENG-XIAN LIN, SHENG-HAO LIN, CHI-CHEN LIN, CHING-CHIEH YANG and SHEAU-YUN YUAN
    Anticancer Research June 2018, 38 (6) 3435-3445; DOI: https://doi.org/10.21873/anticanres.12612
  • You have access
    Postoperative Management of Multiple Primary Cancers Associated with Non-small Cell Lung Cancer
    FUMIHIRO SHOJI, KOJI YAMAZAKI, NAOKO MIURA, MASAKAZU KATSURA, YUKA OKU, SADANORI TAKEO and YOSHIHIKO MAEHARA
    Anticancer Research June 2018, 38 (6) 3773-3778; DOI: https://doi.org/10.21873/anticanres.12660
  • You have access
    Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
    TAKASHI SHINTANI, YUKINORI MATSUO, YUSUKE IIZUKA, TAKAMASA MITSUYOSHI, TAKASHI MIZOWAKI and MASAHIRO HIRAOKA
    Anticancer Research September 2017, 37 (9) 5161-5167;
  • You have access
    Docetaxel in the Treatment of Non-small Cell Lung Cancer (NSCLC) – An Observational Study Focusing on Symptom Improvement
    ANDREAS PIRCHER, INES KRISTIN WASLE, MICHAEL MIAN, GABRIELE GAMERITH, ERNST ULSPERGER, MICHAEL STUDNICKA, ANDREA MOHN-STAUDNER, WOLFGANG HILBE and MICHAEL FIEGL
    Anticancer Research September 2013, 33 (9) 3831-3836;
  • You have access
    Prognostic Value of Preoperative Metabolic Tumor Volumes on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer
    YIN LIN, WAN-YU LIN, CHIA-HUNG KAO, KUO-YANG YEN, SHANG-WEN CHEN and JUN-JUN YEH
    Anticancer Research November 2012, 32 (11) 5087-5091;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire